REG - PageGroup plc - Director/PDMR Shareholding

PagegroupAnnouncement

06/06/2018 10:55

RNS Number : 4994Q
PageGroup plc
06 June 2018
 


 
PageGroup plc (the "Company")
 
 
Notification of Interests of Directors
 
In accordance with Article 19 of the EU Market Abuse Regulation, notification is hereby given of transactions in the ordinary shares of the Company as follows:
 
On 5 June 2018, Steve Ingham sold 650,000 Ordinary shares of 1p each in the Company. Mr Ingham continues to hold 851,625 Ordinary shares.
 
 





1
 




Details of the person discharging managerial responsibilities / person closely associated
 






a)
 




Name
 




Steve Ingham
 






2
 




Reason for the notification
 






a)
 




Position/status
 




Chief Executive Officer






3
 




Details of the issuer, emission allowance market participant, auction platform, auctioneer or
auction monitor
 






a)
 




Name
 




PageGroup plc






b)
 




LEI
 




213800JK5ZEQW4AB8G71






4
 




Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
 
 






a)
 




Description of the financial instrument, type of instrument
 
Identification code
 
 




1p Ordinary shares each in PageGroup plc
 
 
ISIN: GB0030232317






b)
 




Nature of the transaction
 


 
Sale of Ordinary Shares
 






c)
 




Price(s) and volume(s)
 


 





Price(s)
 




Volume(s)




 
£5.46888


 
650,000
 



 
 






d)
 




Aggregated information
 
- Aggregated volume
 
- Price
 
 


 



650,000


£3,554,772
 






e)
 




Date of the transaction
 
 




2018-06-06






f)
 




Place of the transaction
 
 




London Stock Exchange, Main Market (XLON)



 
 
 
Elaine Marriner, Company Secretary        Tel 01932 264148
 
 
 
6 June 2018




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEANKKESAPEEF